Cases 111 - 120 of 197
Allergan Sales LLC et al v. Aurobindo Pharma USA Inc. et al
as 1:2018cv00118
Plaintiff:
Allergan Sales LLC , Allergan USA, Inc. and Forest Laboratories Holdings, Ltd.
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Mallinckrodt IP Unlimited Company et al v. Aurobindo Pharma USA, Inc.
as 1:2017cv01877
Plaintiff:
Mallinckrodt IP Unlimited Company , Mallinckrodt Hospital Products, Inc. and New Pharmatop L.P.
Defendant:
Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Glaxo Group Ltd. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2017cv01862
Plaintiff:
Glaxo Group Ltd. and GlaxoSmithKline LLC
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Aurobindo Pharma USA Inc.
as 1:2017cv01775
Plaintiff:
Pfizer Inc. , Pfizer Limited and Pfizer Ireland Pharmaceuticals
Defendant:
Aurobindo Pharma USA Inc.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA INC.
as 3:2017cv12082
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
AUROBINDO PHARMA USA INC.
Counter_claimant:
AUROBINDO PHARMA USA INC.
Counter_defendant:
CILAG GMBH INTERNATIONAL , JANSSEN PHARMACEUTICA NV , JANSSEN PHARMACEUTICALS, INC. and others
Cause Of Action: 15 U.S.C. § 1126
Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc.
as 1:2017cv01699
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
FOREST LABORATORIES, LLC et al v. AUROBINDO PHARMA USA, INC. et al
as 2:2017cv11679
Plaintiff:
FOREST LABORATORIES, LLC , FOREST LABORATORIES HOLDINGS LIMITED , ALLERGAN USA, INC. and others
Defendant:
AUROBINDO PHARMA USA, INC. and AUROBINDO PHARMA LIMITED
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. AUROBINDO PHARMA USA INC. et al
as 3:2017cv07887
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
AUROBINDO PHARMA USA INC. and EUGIA PHARMA SPECIALITIES LIMITED
Cause Of Action: 15 U.S.C. § 1126
Teijin Limited et al v. Aurobindo Pharma Ltd. et al
as 1:2017cv01314
Plaintiff:
Teijin Limited , Teijin Pharma Limited and Takeda Pharmaceuticals U.S.A., Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.
Cause Of Action: 35 U.S.C. § 271
THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES et al v. AUROBINDO PHARMA USA, INC.
as 3:2017cv06911
Plaintiff:
THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES and THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Defendant:
AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
